• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状旁腺激素水平升高的血钙正常患者。

The Eucalcemic Patient With Elevated Parathyroid Hormone Levels.

作者信息

Shaker Joseph L, Wermers Robert A

机构信息

Department of Medicine and Division of Endocrinology and Molecular Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.

Department of Medicine and Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, USA.

出版信息

J Endocr Soc. 2023 Jan 26;7(4):bvad013. doi: 10.1210/jendso/bvad013. eCollection 2023 Feb 9.

DOI:10.1210/jendso/bvad013
PMID:36793479
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9922947/
Abstract

Primary hyperparathyroidism (PHPT) is classically characterized by hypercalcemia with elevated or inappropriately normal parathyroid hormone (PTH) levels. Elevated PTH levels in the presence of normal calcium levels are not infrequently found during the evaluation of metabolic bone disorders or kidney stone disease. This can be caused by secondary hyperparathyroidism (SHPT) or normocalcemic primary hyperparathyroidism (NPHPT). NPHPT is due to autonomous parathyroid function whereas SHPT is caused by a physiologic stimulation to PTH secretion. Many medical conditions and medications can contribute to SHPT, and differentiation between SHPT and NPHPT may be difficult. Cases are presented to illustrate examples. In this paper, we review the distinction between SHPT and NPHPT as well as end organ effects of NPHPT and outcomes of surgery in NPHPT. We suggest that the diagnosis of NPHPT be made only after careful exclusion of causes of SHPT and consideration of medications that can increase PTH secretion. Further, we advise a conservative approach to surgery in NPHPT.

摘要

原发性甲状旁腺功能亢进症(PHPT)的典型特征是高钙血症伴甲状旁腺激素(PTH)水平升高或正常但不适当。在评估代谢性骨病或肾结石疾病时,经常会发现血钙水平正常但PTH水平升高的情况。这可能是由继发性甲状旁腺功能亢进症(SHPT)或血钙正常的原发性甲状旁腺功能亢进症(NPHPT)引起的。NPHPT是由于甲状旁腺自主功能所致,而SHPT是由对PTH分泌的生理刺激引起的。许多医学状况和药物都可能导致SHPT,区分SHPT和NPHPT可能很困难。本文通过病例举例进行说明。我们回顾了SHPT和NPHPT之间的区别,以及NPHPT的终末器官效应和NPHPT手术的结果。我们建议仅在仔细排除SHPT的病因并考虑可能增加PTH分泌的药物后,才能做出NPHPT的诊断。此外,我们建议对NPHPT采取保守的手术方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eba/9922947/acb572c99276/bvad013f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eba/9922947/acb572c99276/bvad013f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eba/9922947/acb572c99276/bvad013f1.jpg

相似文献

1
The Eucalcemic Patient With Elevated Parathyroid Hormone Levels.甲状旁腺激素水平升高的血钙正常患者。
J Endocr Soc. 2023 Jan 26;7(4):bvad013. doi: 10.1210/jendso/bvad013. eCollection 2023 Feb 9.
2
New parathyroid function index for the differentiation of primary and secondary hyperparathyroidism: a case-control study.新甲状旁腺功能指数在原发性和继发性甲状旁腺功能亢进症鉴别诊断中的应用:一项病例对照研究。
BMC Endocr Disord. 2020 Jan 8;20(1):5. doi: 10.1186/s12902-019-0487-8.
3
Comparisons Between Normocalcemic Primary Hyperparathyroidism and Typical Primary Hyperparathyroidism.血钙正常型原发性甲状旁腺功能亢进症与典型原发性甲状旁腺功能亢进症的比较。
J Korean Med Sci. 2022 Apr 4;37(13):e99. doi: 10.3346/jkms.2022.37.e99.
4
Normocalcemic primary hyperparathyroidism: a survey in a small village of Southern Italy.正常血钙型原发性甲状旁腺功能亢进症:意大利南部一小村庄的调查。
Endocr Connect. 2015 Sep;4(3):172-8. doi: 10.1530/EC-15-0030.
5
Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History.血钙正常型甲状旁腺功能亢进症:患病率及自然病史研究。
J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1171-86. doi: 10.1210/clinem/dgaa084.
6
Parathyroidectomy for Normocalcemic Primary Hyperparathyroidism is Associated with Improved Bone Mineral Density Regardless of Postoperative Parathyroid Hormone Levels.无论术后甲状旁腺激素水平如何,甲状旁腺切除术治疗血钙正常的原发性甲状旁腺功能亢进均与骨密度改善相关。
World J Surg. 2023 Feb;47(2):363-370. doi: 10.1007/s00268-022-06756-x. Epub 2022 Oct 4.
7
Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.血钙正常的原发性甲状旁腺功能亢进症:三级转诊人群中与高钙血症型的比较
Horm Metab Res. 2018 Nov;50(11):797-802. doi: 10.1055/a-0752-4533. Epub 2018 Nov 5.
8
Assessment of Vitamin D Status in Primary Hyperparathyroidism Patients: A Retrospective Study.原发性甲状旁腺功能亢进患者维生素D状态评估:一项回顾性研究。
Cureus. 2024 Jul 20;16(7):e64988. doi: 10.7759/cureus.64988. eCollection 2024 Jul.
9
Normocalcemic Hyperparathyroidism.血钙正常型甲状旁腺功能亢进症。
Front Horm Res. 2019;51:23-39. doi: 10.1159/000491036. Epub 2018 Nov 19.
10
Normocalcaemic primary hyperparathyroidism: is nephrolithiasis more common than osteoporosis?血钙正常型原发性甲状旁腺功能亢进:肾结石比骨质疏松更常见吗?
Intern Med J. 2023 Jan;53(1):112-118. doi: 10.1111/imj.15502. Epub 2022 Jul 19.

引用本文的文献

1
Bilateral Basal Ganglia Calcifications in a 61-Year-Old Woman With Normocalcemic Hyperparathyroidism.一名61岁血钙正常的甲状旁腺功能亢进女性的双侧基底节钙化
AACE Endocrinol Diabetes. 2025 Apr 10;12(1):36-40. doi: 10.1016/j.aed.2025.03.001. eCollection 2025 May-Jun.
2
Case Report: Falsely elevated PTH level in a young woman caused by immunoassay interference resulting from macro-PTH.病例报告:一名年轻女性因大分子甲状旁腺激素导致免疫测定干扰,甲状旁腺激素水平假性升高。
Front Endocrinol (Lausanne). 2025 Apr 11;16:1564352. doi: 10.3389/fendo.2025.1564352. eCollection 2025.
3
Dietary calcium intake in primary hyperparathyroidism and in its normocalcemic variant: a case-control study.

本文引用的文献

1
Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop.原发性甲状旁腺功能亢进的评估与管理:第五次国际研讨会总结声明和指南。
J Bone Miner Res. 2022 Nov;37(11):2293-2314. doi: 10.1002/jbmr.4677. Epub 2022 Oct 17.
2
Classical and Nonclassical Manifestations of Primary Hyperparathyroidism.原发性甲状旁腺功能亢进的经典和非经典表现。
J Bone Miner Res. 2022 Nov;37(11):2330-2350. doi: 10.1002/jbmr.4679. Epub 2022 Oct 17.
3
Surgical Aspects of Primary Hyperparathyroidism.
原发性甲状旁腺功能亢进及其血钙正常变异型中的膳食钙摄入量:一项病例对照研究。
Front Endocrinol (Lausanne). 2025 Feb 3;15:1428640. doi: 10.3389/fendo.2024.1428640. eCollection 2024.
4
PTH immunoassay interference: differential diagnosis with normocalcemic primary hyperparathyroidism?PTH 免疫测定干扰:伴有血钙正常的原发性甲状旁腺功能亢进症的鉴别诊断?
Arch Endocrinol Metab. 2024 Nov 6;68:e230315. doi: 10.20945/2359-4292-2023-0315. eCollection 2024.
5
Osteoporosis and Normocalcemic Primary Hyperparathyroidism (Conservatively or Surgically Managed).骨质疏松症与血钙正常的原发性甲状旁腺功能亢进症(保守治疗或手术治疗)
J Clin Med. 2024 Oct 23;13(21):6325. doi: 10.3390/jcm13216325.
6
Brown Tumors: The Hidden Face of Primary and Renal Hyperparathyroidism Amid Real-Life Settings.棕色瘤:现实环境中原发性和肾性甲状旁腺功能亢进的隐匿面貌。
J Clin Med. 2024 Jun 29;13(13):3847. doi: 10.3390/jcm13133847.
7
Comparison of Normocalcemic vs Hypercalcemic Primary Hyperparathyroidism in a Hypercalciuric Renal Stone Population.高钙尿性肾结石人群中正常血钙与高钙血症原发性甲状旁腺功能亢进的比较。
J Clin Endocrinol Metab. 2024 Sep 16;109(10):2553-2560. doi: 10.1210/clinem/dgae162.
8
Age-specific Reference Intervals of Abbott Intact PTH-Potential Impacts on Clinical Care.雅培全段甲状旁腺激素的年龄特异性参考区间——对临床护理的潜在影响
J Endocr Soc. 2024 Jan 12;8(3):bvae004. doi: 10.1210/jendso/bvae004. eCollection 2024 Jan 16.
9
The association between proton pump inhibitors and hyperparathyroidism: a potential mechanism for increased fracture-results of a large observational cohort study.质子泵抑制剂与甲状旁腺功能亢进症的关联:增加骨折的潜在机制-一项大型观察性队列研究结果。
Osteoporos Int. 2023 Nov;34(11):1917-1926. doi: 10.1007/s00198-023-06867-8. Epub 2023 Aug 2.
10
Incidence of Primary Hyperparathyroidism in the Current Era: Have We Finally Reached a Steady State?当代原发性甲状旁腺功能亢进症的发病率:我们最终达到稳定状态了吗?
J Clin Endocrinol Metab. 2023 Nov 17;108(12):e1749-e1750. doi: 10.1210/clinem/dgad267.
原发性甲状旁腺功能亢进的手术治疗。
J Bone Miner Res. 2022 Nov;37(11):2373-2390. doi: 10.1002/jbmr.4689. Epub 2022 Oct 17.
4
Calcium Challenge to Confirm Secondary Hyperparathyroidism Caused by Decreased Calcium Intake.钙挑战以确认因钙摄入减少引起的继发性甲状旁腺功能亢进。
Endocr Pract. 2022 Oct;28(10):1069-1071. doi: 10.1016/j.eprac.2022.07.009. Epub 2022 Jul 21.
5
The Diagnosis of Normocalcaemic Hyperparathyroidism is Strikingly Dissimilar Using Different Commercial Laboratory Assays.不同商业实验室检测对血钙正常甲状旁腺功能亢进症的诊断有显著差异。
Horm Metab Res. 2022 Jul;54(7):429-434. doi: 10.1055/a-1856-4900. Epub 2022 Jul 14.
6
Mortality and Morbidity in Mild Primary Hyperparathyroidism: Results From a 10-Year Prospective Randomized Controlled Trial of Parathyroidectomy Versus Observation.轻度原发性甲状旁腺功能亢进症的死亡率和发病率:甲状旁腺切除术与观察的 10 年前瞻性随机对照试验结果。
Ann Intern Med. 2022 Jun;175(6):812-819. doi: 10.7326/M21-4416. Epub 2022 Apr 19.
7
Reduced fracture incidence in patients having surgery for primary hyperparathyroidism.原发性甲状旁腺功能亢进症患者手术治疗后骨折发生率降低。
Clin Endocrinol (Oxf). 2022 Sep;97(3):276-283. doi: 10.1111/cen.14703. Epub 2022 Mar 4.
8
Normocalcemic primary hyperparathyroidism: 99mTc SestaMibi SPECT/CT results compare with hypercalcemic hyperparathyroidism.血钙正常的原发性甲状旁腺功能亢进症:99mTc 甲氧基异丁基异腈单光子发射计算机断层扫描/计算机断层扫描结果与高钙血症性甲状旁腺功能亢进症的比较。
Clin Endocrinol (Oxf). 2022 Jun;96(6):831-836. doi: 10.1111/cen.14667. Epub 2022 Jan 4.
9
European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders.《欧洲专家共识:成人和妊娠甲状旁腺疾病特定方面的实用管理:甲状旁腺疾病 ESE 教育计划的建议》。
Eur J Endocrinol. 2022 Jan 13;186(2):R33-R63. doi: 10.1530/EJE-21-1044. Print 2022 Feb 1.
10
Evaluation and Management of Elevated Parathyroid Hormone Levels in Normocalcemic Patients.血钙正常患者甲状旁腺激素水平升高的评估与管理。
Med Clin North Am. 2021 Nov;105(6):1135-1150. doi: 10.1016/j.mcna.2021.05.017. Epub 2021 Sep 7.